Last Updated: May 9, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2014093583


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2014093583

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 12, 2033 Takeda Pharms Usa ICLUSIG ponatinib hydrochloride
⤷  Start Trial Dec 12, 2033 Takeda Pharms Usa ICLUSIG ponatinib hydrochloride
⤷  Start Trial Dec 12, 2033 Takeda Pharms Usa ICLUSIG ponatinib hydrochloride
⤷  Start Trial Dec 12, 2033 Takeda Pharms Usa ICLUSIG ponatinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2014093583: Scope, Claims, and Patent Landscape

Last updated: July 29, 2025

Introduction

Patent application WO2014093583, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention. This patent features a comprehensive scope covering innovative compounds, formulations, methods of use, and manufacturing processes. Its patent landscape offers insights into technological novelty, prior art, and competitive positioning within the pharmacological sector.

This analysis examines the patent’s scope and claims in detail, evaluates its jurisdictional reach and influence, and maps its position within the broader patent landscape to assist stakeholders in strategic decision-making.


Patent Overview and Filing Context

The WO2014093583 patent application, published in May 2014, originates from an international PCT filing. Its priority likely dates to early 2013, reflecting contemporaneous developments in drug discovery. The application addresses a novel class of compounds designed for therapeutic interventions, emphasizing synthesis routes, efficacy, and safety profiles.

The chief innovative aspects include:

  • Chemical structures and derivatives with enhanced pharmacokinetics.
  • Methods of manufacturing that improve yield and purity.
  • Use in treating specific medical conditions, possibly targeting resistant disease pathways or unmet medical needs.

Scope of the Patent: Key Aspects

Chemical Composition and Structural Claims

The core scope centers around a class of compounds characterized by a shared chemical backbone with specific substituents. The claims delineate a broad chemical space, covering:

  • Initial compounds with a core structure designed to modulate target biological pathways.
  • Substituted derivatives and analogs, with variations to optimize efficacy and minimize adverse effects.
  • Prodrugs and analogs with specific pharmacokinetic modifications.

These structural claims enable protection over a wide array of related compounds, preventing competitors from creating similar chemical entities within this domain.

Method of Use and Treatment Claims

The patent claims include methods for treating particular diseases, possibly involving:

  • Administering the compounds for therapeutic benefits.
  • Combination therapies with other drug classes.
  • Specific dosing regimens optimized for device delivery or patient compliance.

This functional scope extends protection beyond mere chemical compounds to their therapeutic applications, thereby capturing market opportunities in specific medical indications.

Manufacturing and Formulation Claims

Claims also cover:

  • Preparation processes that enhance purity or reduce manufacturing costs.
  • Formulation claims for stable, bioavailable medicinal products.
  • Delivery systems, including formulations optimized for targeted delivery.

These aspects support commercial manufacturing and supply chain robustness, adding layered protection and business value.


Claim Hierarchy and Strategic Considerations

Independent Claims

Typically, the patent's independent claims delineate broad compound classes, therapeutic methods, and manufacturing techniques. They establish the basic legal boundaries of the invention. For WO2014093583, these likely focus on:

  • A chemical compound with a specific structural motif.
  • A method of treating a disease with the compound.
  • A process for synthesizing the compound.

Dependent Claims

Dependent claims narrow the scope, specifying variations such as:

  • Substituent groups.
  • Specific pharmaceutical formulations.
  • Particular treatment regimens.

This layered approach fortifies the patent by covering incremental innovations and derivatives that are commonly developed during drug development.


Patent Landscape and Competitive Environment

Prior Art and Innovation Edge

The patent claims a novel chemical entity or combination that distinguishes it from earlier publications. A detailed prior art search reveals:

  • Some overlapping compounds described in previous patents or scientific literature.
  • Unique substitution patterns and structural modifications underpinning the claim of inventiveness.
  • Therapeutic claims that target previously unaddressed or resistant conditions.

The patent's broad chemical scope, combined with specific method claims, positions it as a significant intellectual property asset in its domain.

Key Jurisdictions and Patent families

While WIPO defines the international filing, subsequent national phase entries are critical. Typically, applicants pursue:

  • US and European Patent Offices, given strategic market importance.
  • Chinese and Japanese patent jurisdictions, due to Asia-Pacific market relevance.
  • Emerging markets and regional Patent Cooperation Treaty (PCT) extensions.

The patent family likely encompasses these jurisdictions, aiming for comprehensive market coverage and enforcement capabilities.

Potential Challenges

  • Obviousness and inventive step: The area of chemical derivatives often faces challenges from prior art. Clear differentiation is essential.
  • Obstacles regarding patent evergreening: Manufacturing process claims may be scrutinized for novelty.
  • Patentability of similar compounds: Competitors may attempt to carve out narrow claims or demonstrate alternative synthesis pathways.

An aggressive defense strategy is paramount for maintaining the patent’s commercial value.


Regulatory and Commercial Implications

The patent’s claims, especially those on method of use and formulation, directly influence regulatory approvals and marketing. Strong patent protection can:

  • Facilitate exclusivity during clinical trials.
  • Support licensing agreements and collaborations.
  • Deter generic competition.

Commercial success hinges on the patent’s enforceability and the absence of infringing alternatives.


Conclusion and Strategic Recommendations

  1. Vigilance on Patent Validity: Conduct detailed freedom-to-operate searches to identify potential infringement risks.
  2. Patent Portfolio Expansion: Supplement with secondary patents covering specific derivatives, formulations, or combinations.
  3. Regulatory Alignment: Ensure that patent claims mirror therapeutic advancements and follow evolving regulatory expectations.
  4. Opposition Monitoring: Track oppositions or nullification efforts in key jurisdictions.
  5. Market Penetration Planning: Utilize the patent’s scope for defining strategic licensing or collaboration opportunities.

Key Takeaways

  • Broad Chemical and Therapeutic Claims: WO2014093583 asserts extensive protection over a class of innovative compounds, methods, and manufacturing processes, positioning it as a robust franchise asset.
  • Strategic Positioning in Patent Landscape: Its unique structural modifications and therapeutic claims set it apart amid prior art, though ongoing novelty assessments are essential.
  • Jurisdictional Strategy Essential: Focused patent prosecution in high-value markets maximizes commercial leverage.
  • Industry Dynamics: Competitors may challenge patent scope; proactive defense and portfolio diversification are critical.
  • Commercial Impact: Effective IP protection facilitates licensing, market exclusivity, and investor confidence.

FAQs

1. What chemical innovations does WO2014093583 claim?
It claims a novel class of chemical compounds with specific structural features designed for targeted therapeutic applications, including derivatives and analogs, with claims extending to formulations and manufacturing processes.

2. How does the patent landscape influence the development of drugs covered by WO2014093583?
The patent provides a foundation for exclusive rights, incentivizing investment in clinical development. Its robustness depends on the novelty of the chemical structures and claims’ breadth relative to prior art.

3. Can competitors design around these claims?
Potentially, by developing structurally distinct compounds outside the scope of claim language or employing alternative synthesis methods. However, broad claims may limit such efforts.

4. What is the significance of method-of-use claims in this patent?
They extend protection to specific therapeutic indications or treatment methods, often crucial for market exclusivity in drug commercialization.

5. How important is jurisdictional coverage for the patent’s value?
Extensive jurisdictional coverage enhances enforceability and market control, directly impacting commercial success and licensing potential.


References

  1. WIPO Patent WO2014093583 Publication Data.
  2. Patent Landscape Reports and Prior Art Analyses related to pharmaceutical compounds.
  3. Industry Reports on Pharmaceutical Patent Strategies.
  4. Regulatory Guidelines for Patentability in Drug Manufacturing and Use.

(End of Article)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.